December 1, 2016 - By Clifton Ray · 0 Comments
The stock of DNB ASA ORD (OTCMKTS:DNBHF) registered a decrease of 16.22% in short interest. DNBHF’s total short interest was 449,400 shares in December as published by FINRA. Its down 16.22% from 536,400 shares, reported previously. With 1,400 shares average volume, it will take short sellers 321 days to cover their DNBHF’s short positions. The stock last traded at $14.17 per share. It is down 16.63% since April 28, 2016 and is uptrending. It has outperformed by 10.70% the S&P500.
Out of 3 analysts covering DNB ASA (OTCMKTS:DNBHF), 2 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive. DNB ASA has been the topic of 4 analyst reports since October 23, 2015 according to StockzIntelligence Inc. On Tuesday, December 8 the stock rating was initiated by Jefferies with “Underperform”. On Thursday, November 17 the stock rating was upgraded by Jefferies to “Buy”. The company was upgraded on Friday, October 7 by JP Morgan. The stock of DNB ASA NOK10 (OTCMKTS:DNBHF) has “Neutral” rating given on Friday, October 23 by Citigroup.
Another recent and important DNB ASA NOK10 (OTCMKTS:DNBHF) news was published by Globenewswire.com which published an article titled: “BIONOR PHARMA – CONTEMPLATED PRIVATE PLACEMENT” on November 23, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Clifton Ray